Green Queen Media’s Post

India is set to host the inaugural NUTRIFY C-SUITE SUMFLEX – INNOVATION BATTLEFIELD, marking the country's first-ever live investment bids for equity in Nutraceutical Innovations. This groundbreaking initiative is bolstered by a prestigious collaboration with the Office of the Principal Scientific Adviser to the Government of India, which has agreed to be the Knowledge Partner for the event. This partnership emphasizes the event's significance and its alignment with the highest standards of scientific and technological innovation. Furthermore, the NUTRIFY TODAY C-Suite Sumflex - Innovation Battlefield will be featured on the esteemed MANTHAN portal, an iconic initiative led by the Office of the Principal Scientific Adviser to the Government of India (PSA). MANTHAN is known for its dedication to transforming the science and technology landscape through social impact innovations and solutions across India. The application window for innovation investment pitches is open until 25th April 2024. Act quickly to secure a chance to be on stage at the Global Nutrify C-Suite Sumflex 2024 on 6th June at the Taj Mahal Palace, and to potentially raise investment cumulatively up to INR 5 crore / USD 560,000. The application window is closing soon. Apply today to transform your vision into reality. Registration Link: https://lnkd.in/dRatQknz #ntcsuitesummit #manufacturing #leaders #nutraceuticals #pharmaceuticals #nutrition #innovation #wellness #growth #bussiness #opportunity2024 #foodtech #lifesciences #transformation #pharmaindustry #dietarysupplements #ingredients

#ZydusLifesciences has entered into a significant agreement with Temasek-backed Perfect Day to acquire a 50% stake in STERLING Biotech Ltd. - India. The deal will establish Sterling Biotech as a 50:50 joint venture (JV) with equal board representation from both parties, according to a statement from Zydus Lifesciences. Under the agreement, Zydus Animal Health Limited, a wholly owned subsidiary of Zydus, will acquire 322 crore equity shares of #SterlingBiotech, each valued at Rs 1, representing 50% of the company’s paid-up share capital. The newly formed JV plans to build a cutting-edge manufacturing facility focused on producing fermented, animal-free protein to serve global markets. This acquisition marks Zydus’ entry into the specialized biotech sector, targeting health and nutrition products for consumers who prefer or require animal-free protein, including those with lactose intolerance. The joint venture aims to boost the production of high-quality, eco-friendly protein products, align with growing consumer demand for fermentation-based and ethically sourced nutrition, and reduce environmental impact. AZB & Partners advised Perfect Day Inc. on this transaction. The deal team comprised our Senior Partners Hardeep Sachdeva and Ravi Bhasin, Partner Sudish Sharma, Senior Associate Gursimran K. Druheen Mohanty and Associate Ananya Nigam; with support from Associates Ananya Singh, Ayushi Mukherjee, Sakshi Bhatnagar, Seema Bindal, Mahak Kharb and Damini Sinha. They were also supported by Partner Sumit Mangal, Associates Radhika Sharma, Akshat Jain and Abhishek Rai on tax issues. Senior Partner Akhilesh Kumar Rai provided support on IP related aspects and Senior Partner Suresh Varanasi and Counsel Sagnik Chatterjee supported on indirect tax aspects. #Deal #Transactions #Lawfirms #Mumbai #India

Following the news of its letter of no questions or objections from the FDA in the US for its cell-cultured whey protein product, #precisionfermentation #dairy startup Imagindairy also acquired and is operating its own industrial-scale production lines. The new production lines and the associated downstream processing capabilities give the startup access to 100,000 liters of fermentation capacity, with planned expansion to triple the volume in the next 1-2 years. With the new production lines and FDA letter, Imagindairy expects to launch a beta-lactoglobulin whey product in the US this year. The startup did not disclose the cost of acquiring the production lines or the facility location. #cellag #scaling #futureoffood

🥛 Could we soon see more affordable alternative dairy products in supermarkets? Israeli startup Imagindairy has taken a major step forward in the animal-free dairy sector by acquiring industrial-scale precision fermentation production lines near Israel. This strategic move provides Imagindairy with 100,000 liters of fermentation capacity, with plans to triple it within the next 1-2 years. The company has recently received FDA approval for the Generally Recognized as Safe (GRAS) status of its animal-free whey protein, setting the stage for the launch of innovative whey protein products in the US later this year. Imagindairy's acquisition allows it to offer cost-competitive animal-free dairy products without compromising quality, facilitating mass-market adoption and supporting its transition to an industrial-scale operation. Learn more in the full article: https://lnkd.in/d-KFnpTK #ForwardFooding #precisionfermentation #altprotein #innovation #foodtech #foodsystems

Thoughts on this? >> Biotech startup raises $38 million to build mycoprotein plant in Finland - IntraFish >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #competitivemarketing #pharma #pharmaceutical

FLORIDA GOVERNOR VETOS LEGISLATURE'S PROPOSED RESTRICTIONS ON HEMP-DERIVED PRODUCTS  Florida Governor Ron DeSantis just issued his formal veto of Senate Bill 1698, which lawmakers passed during the 2024 legislative session. SB 1698, sought to make several substantive changes to Florida’s Hemp Program, including: ·        REVISING the definition of “hemp extract” to include hemp intended for inhalation and to prohibit it from containing statutorily defined controlled substances, as well as any quantity of synthetic cannabinoids, e.g., delta-8- or delta-10 THC; THCA, HHC, THCV or THCP; ·        CREATING a definition for “total delta-9-tetrahydrocannabinol concentration” to mean a concentration calculated as: delta-9-tetrahydrocannabinol] + (0.877 x [delta-9-tetrahydrocannabinolic acid]; ·       AMENDING the definition of “hemp” to “outline that hemp extract may not exceed 0.3 percent total delta-9-tetrahydrocannabinol concentration on a wet-weight basis or exceed 5 milligrams per serving and 50 milligrams per container on a wet-weight basis, whichever is less; ·       SPECIFYING that if a hemp extract product is sold at retail it must meet the new requirements for total delta-9-THC concentration limits, and the packaging must include the toll-free telephone number for the national Poison Help line; ·       PROHIBITING a business or food establishment from selling or possessing hemp extract products that are “attractive to children;” and ·       REQUIRING that before holding an event where hemp extract products are sold or marketed, an event organizer must provide the Florida Department of Agriculture and Consumer Services with a list of the businesses selling or marketing hemp extract products at the event and verify that each business is only selling hemp products from an approved source. The event organizer also must ensure that each participating business is properly permitted. The legislation also would have prevented existing retailers of hemp-derived products from removing or using, except for disposal, hemp extract products subject to a stop-sale order which are attractive to children until the Ag-Department determines that the hemp extract products comply with state law. This was especially concerning to industry members who currently hold hundreds of thousands of dollars work of hemp-derivative products in inventory. The Governor's veto statement noted that small businesses are the cornerstone of Florida's economy. "While Senate Bill 1698's goals are commendable, the bill would, in fact, impose debilitating regulatory burdens on small businesses and almost certainly fail to achieve its purposes." #Floridahemp #SB1698 #hempderivatives

Danish biotech company Novozymes has finalized its merger with Chr. Hansen, marking a significant #milestone since its Kenya debut in June 2019. Novozymes specializes in innovative biological solutions, such as industrial enzymes and #microorganisms, catering to various sectors like household care, #brewing, #baking, and #bio-agriculture. Notably, one of its solutions prolongs #bread freshness, combating food waste. Chr. Hansen, established in 1874, complements Novozymes by supplying bacteria cultures, probiotics, and #enzymes necessary for #production. The merged entity, now known as Novonesis, has secured all regulatory approvals and registrations, including with the Danish Business Authority. With a global workforce of 10,000, Novonesis spans 30 #industries, aiming to pioneer #climate-friendly #food products and sustainable solutions to reduce CO2 emissions. Novonesis, led by President and CEO Ester Baiget, vows to drive innovation in biosolutions, leveraging its combined expertise and biological toolbox. Cees de Jong, Chairman of Novonesis, reaffirms the company's commitment to customer-centric biosolutions, drawing on over a #century of innovation. With an annual revenue of approximately EUR 3.7 billion, Novonesis focuses on #promoting healthier #lifestyles, improving #food quality, and advancing eco-friendly practices. #merger #hakunamatatamedia Story: Metropol TV

For years, Afghanistan has been the world's premier cultivator of poppy used as the base for heroin distributed in Europe, Africa and Canada according to the key findings of the United Nations Office on Drugs and Crime's (UNODC) World Drug Report 2024, while the Americas have largely been supplied with product derived from poppy plantations in Mexico and Colombia. With the Taliban retaking power in April 2022, the new Afghan government instituted a strict ban on the cultivation of poppy, not only curtailing the supply of illicit substances like heroin but also that of medical prescription opioids. As a result, potential opium production dropped by 95 percent between 2022 and 2023 to 333 tons. As our chart based on UNODC data shows, this change makes Myanmar the country with the highest opium production potential in 2023. The Southeast Asian country more than doubled its estimated capabilities in this segment compared to 2021 and is trailed by Mexico with a potential production of oven-dry opium of 166 in 2022, with estimates for the past year still outstanding. While Laos and Colombia are grouped into other countries in the chart due to limited data availability. However, they contributed to global opium production with 41 tons in 2019 and 18 tons in 2018, respectively. Apart from the U.S. invasion of the country in 2001, the cultivation of poppy has been a significant part of Afghan agriculture for the past decades, rarely dropping below levels of 2,500 tons of estimated opium produced between 1994 and 2022. While the curbing of the production capabilities of drugs like heroin can in theory be seen as a net positive, many farmers in the country heavily relied on their poppy fields for their monthly income, and the resulting increasing prices for heroin gave rise to new and arguably more dangerous substances like fentanyl. https://lnkd.in/euYi7ub7

Grateful for the opportunity to partner with Inventicon Business Intelligence Pvt. Ltd. for the 9th Annual Nutrition India Summit 2024 as an associate partner! Our CEO, Mr. Vinayak Patankar will be delivering a keynote speech on our strides in the nutrition industry, contributing to our nation's self-reliance journey. Join us for an engaging discussion on industry insights and advancements. We look forward to seeing you there! #Inventicon #NutritionIndiaSummit #BorosilScientific #NutritionIndustry #SelfReliantNation"